Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome ...
Type 1 diabetes researchers have made great progress in understanding the disease in the last two decades, even as a cure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results